Staci Circello
Family · Geneseo, ILNPI 1164065801
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $618 and has fallen 58.6% since, to $256 in 2025.
Across 98 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$231
- AbbVie$207
- Novo Nordisk$191
- Exact Sciences$186
- Novartis$141
- Lilly USA, LLC$136
- plus $563 from 13 others
What the payments were for
- Food & beverage$1,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $231 |
| AbbVie | 15 | $207 |
| Novo Nordisk | 12 | $191 |
| Exact Sciences | 12 | $186 |
| Novartis | 9 | $141 |
| Lilly USA, LLC | 9 | $136 |
| Organon | 5 | $87 |
| Amgen | 3 | $62 |
| Boehringer Ingelheim | 3 | $62 |
| Bayer | 4 | $57 |
| Dexcom, Inc. | 2 | $48 |
| Eisai Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Almatica Pharma LLC | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
How this compares
$1,655 in reported general payments places this provider in the 80th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 87 | $1,026 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 46 | $675 |
| Methylprednisolone | 73 | $495 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $440 |
| Azithromycin | 82 | $339 |
| Prednisone | 144 | $224 |
| Nystatin | 12 | $181 |
| Ciprofloxacin Hcl | 27 | $173 |
| Cephalexin | 23 | $109 |
| Amoxicillin | 28 | $99 |
| Cyclobenzaprine Hcl | 13 | $76 |
| Triamcinolone Acetonide | 18 | $76 |
| Meclizine Hcl | 16 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $66 |
| Fluconazole | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in Geneseo
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.